Burzynski Research Stock Today
| BZYR Stock | USD 0.04 0.01 28.57% |
Performance4 of 100
| Odds Of DistressLess than 43
|
Burzynski Research is selling at 0.035 as of the 28th of November 2024; that is 28.57 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.035. Burzynski Research has about a 43 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Burzynski Research are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas. Burzynski Research is traded on OTC Exchange in the United States. The company has 131.45 M outstanding shares. More on Burzynski Research
Moving against Burzynski Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Burzynski Pink Sheet Highlights
| Chairman | Stanislaw Burzynski |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Burzynski Research [BZYR] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Burzynski Research's market, we take the total number of its shares issued and multiply it by Burzynski Research's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Burzynski Research conducts business under Biotechnology sector and is part of Health Care industry. The entity has 131.45 M outstanding shares.
Burzynski Research currently holds about 1.27 K in cash with (325.1 K) of positive cash flow from operations.
Check Burzynski Research Probability Of Bankruptcy
Ownership AllocationBurzynski Research holds a total of 131.45 Million outstanding shares. Burzynski Research shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 81.01 percent of Burzynski Research outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Burzynski Ownership Details
Burzynski Research Risk Profiles
| Mean Deviation | 7.61 | |||
| Semi Deviation | 9.51 | |||
| Standard Deviation | 16.72 | |||
| Variance | 279.61 |
Burzynski Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Burzynski Research without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Additional Tools for Burzynski Pink Sheet Analysis
When running Burzynski Research's price analysis, check to measure Burzynski Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burzynski Research is operating at the current time. Most of Burzynski Research's value examination focuses on studying past and present price action to predict the probability of Burzynski Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burzynski Research's price. Additionally, you may evaluate how the addition of Burzynski Research to your portfolios can decrease your overall portfolio volatility.